Skip to content
Disclosery

EXANE DERIVATIVES: SPOT position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on SPOT, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 468 SPOT shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 468 shares
    Change vs previous 13F -581 shares

    0.03% of the 13F portfolio, value $43,903.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 1,049 shares
    Change vs previous 13F +368 shares

    0.04% of the 13F portfolio, value $158,408.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 681 shares
    Change vs previous 13F -558 shares

    0.04% of the 13F portfolio, value $159,366.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 1,239 shares
    Change vs previous 13F +200 shares

    0.07% of the 13F portfolio, value $279,182.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 1,039 shares
    Change vs previous 13F +48 shares

    0.06% of the 13F portfolio, value $274,132.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 991 shares
    Change vs previous 13F +491 shares

    0.08% of the 13F portfolio, value $265,522.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2020-12-31
    13F 500 shares
    Change vs previous 13F +494 shares

    0.05% of the 13F portfolio, value $157,320.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2020-09-30
    13F/A 6 shares
    Change vs previous 13F not available

    <0.01% of the 13F portfolio, value $1,455.

    13F-HR/A 0001623883-20-000010 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).